autologous CAR T cells KITE-197
Term · Oncology and biomedicine · MLC-T-ONC-011521
A preparation of autologous T lymphocytes that have been genetically engineered to express a chimeric antigen receptor (CAR) with an as of yet undisclosed target, with potential immunomodulating and antineoplastic activities. Upon administration, autologous CAR T cells KITE-197 specifically recognize and kill tumor cells expressing the as of yet undisclosed antigen target. This results in a cytotoxic T-lymphocyte (CTL) response against these tumor cells, thereby causing tumor cell lysis.
| Identifier | MLC-T-ONC-011521 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | autologous CAR-T cells KITE-197 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011521",
"term": "autologous CAR T cells KITE-197",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous T lymphocytes that have been genetically engineered to express a chimeric antigen receptor (CAR) with an as of yet undisclosed target, with potential immunomodulating and antineoplastic activities. Upon administration, autologous CAR T cells KITE-197 specifically recognize and kill tumor cells expressing the as of yet undisclosed antigen target. This results in a cytotoxic T-lymphocyte (CTL) response against these tumor cells, thereby causing tumor cell lysis.",
"synonyms": [
"autologous CAR-T cells KITE-197"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-car-t-cells-kite-197/"
}
Record 2,855 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.